Panacea Biotec Limited (PANACEABIO.NS)

INR 544.6

(-1.37%)

Total Liabilities Summary of Panacea Biotec Limited

Panacea Biotec Limited's latest annual total liabilities in 2023 was 4.02 Billion INR , down -6.73% from previous year.
Panacea Biotec Limited's latest quarterly total liabilities in 2024 Q1 was -8.38 Billion INR , down -308.5% from previous quarter.
Panacea Biotec Limited reported annual total liabilities of 4.31 Billion INR in 2022, down -53.98% from previous year.
Panacea Biotec Limited reported annual total liabilities of 9.36 Billion INR in 2021, down -33.59% from previous year.
Panacea Biotec Limited reported quarterly total liabilities of 4.28 Billion INR for 2023 Q2, down 0.0% from previous quarter.
Panacea Biotec Limited reported quarterly total liabilities of - INR for 2023 Q1, down -100.0% from previous quarter.

Annual Total Liabilities Chart of Panacea Biotec Limited (2023 - 2004)

Historical Annual Total Liabilities of Panacea Biotec Limited (2023 - 2004)

Year	Total Liabilities	Total Liabilities Growth
2023	4.02 Billion INR	-6.73%
2022	4.31 Billion INR	-53.98%
2021	9.36 Billion INR	-33.59%
2020	14.1 Billion INR	18.08%
2019	11.94 Billion INR	16.19%
2018	10.28 Billion INR	-21.02%
2017	13.01 Billion INR	-11.12%
2016	14.64 Billion INR	4.27%
2015	14.04 Billion INR	-3.51%
2014	14.55 Billion INR	2.15%
2013	14.25 Billion INR	18.13%
2012	12.06 Billion INR	7.34%
2011	11.23 Billion INR	4.21%
2010	10.78 Billion INR	10.04%
2009	9.8 Billion INR	-10.23%
2008	10.91 Billion INR	80.84%
2007	6.03 Billion INR	21.67%
2006	4.96 Billion INR	-35.12%
2005	7.64 Billion INR	195.24%
2004	2.59 Billion INR	0.0%

Year	Total Liabilities	Total Liabilities Growth
2024 Q1	-8.38 Billion INR	-308.5%
2023 Q2	4.28 Billion INR	0.0%
2023 Q1	- INR	-100.0%
2023 FY	4.02 Billion INR	-6.73%
2023 Q4	4.02 Billion INR	0.0%
2023 Q3	- INR	-100.0%
2022 FY	4.31 Billion INR	-53.98%
2022 Q1	- INR	-100.0%
2022 Q2	5.45 Billion INR	0.0%
2022 Q3	- INR	-100.0%
2022 Q4	4.31 Billion INR	0.0%
2021 Q4	9.36 Billion INR	0.0%
2021 Q2	15.89 Billion INR	0.0%
2021 FY	9.36 Billion INR	-33.59%
2021 Q1	- INR	-100.0%
2021 Q3	- INR	-100.0%
2020 FY	14.1 Billion INR	18.08%
2020 Q2	12.77 Billion INR	0.0%
2020 Q4	14.1 Billion INR	0.0%
2020 Q1	- INR	-100.0%
2020 Q3	- INR	-100.0%
2019 Q4	11.94 Billion INR	0.0%
2019 Q3	- INR	-100.0%
2019 Q2	11.49 Billion INR	0.0%
2019 Q1	- INR	-100.0%
2019 FY	11.94 Billion INR	16.19%
2018 Q4	10.28 Billion INR	0.0%
2018 FY	10.28 Billion INR	-21.02%
2017 FY	13.01 Billion INR	-11.12%
2016 FY	14.64 Billion INR	4.27%
2015 FY	14.04 Billion INR	-3.51%
2014 FY	14.55 Billion INR	2.15%
2013 FY	14.25 Billion INR	18.13%
2012 FY	12.06 Billion INR	7.34%
2011 FY	11.23 Billion INR	4.21%
2010 FY	10.78 Billion INR	10.04%
2009 FY	9.8 Billion INR	-10.23%
2008 FY	10.91 Billion INR	80.84%
2007 FY	6.03 Billion INR	21.67%
2006 FY	4.96 Billion INR	-35.12%
2005 FY	7.64 Billion INR	195.24%
2004 FY	2.59 Billion INR	0.0%

Peer Total Liabilities Comparison of Panacea Biotec Limited

Name	Total Liabilities	Total Liabilities Difference
Biocon Limited	307.95 Billion INR	98.695%
Blue Jet Healthcare Limited	2.13 Billion INR	-88.191%
Concord Biotech Limited	1.74 Billion INR	-130.962%
Dishman Carbogen Amcis Limited	39.53 Billion INR	89.832%
Jubilant Ingrevia Limited	19.94 Billion INR	79.843%
Lyka Labs Limited	884.58 Million INR	-354.472%
Piramal Pharma Limited	74 Billion INR	94.568%
SMS Lifesciences India Limited	1.96 Billion INR	-104.193%
Supriya Lifescience Limited	1.05 Billion INR	-279.73%
Syngene International Limited	18.93 Billion INR	78.773%
TAKE Solutions Limited	969.78 Million INR	-314.548%
Zota Health Care Limited	1.38 Billion INR	-190.578%